Sartorius Aktiengesellschaft (OTCMKTS:SARTF – Get Rating) – Stock analysts at KeyCorp decreased their Q3 2022 earnings per share (EPS) estimates for shares of Sartorius Aktiengesellschaft in a note issued to investors on Thursday, July 21st. KeyCorp analyst P. Knight now anticipates that the company will post earnings per share of $2.30 for the quarter, down from their prior estimate of $2.48. The consensus estimate for Sartorius Aktiengesellschaft’s current full-year earnings is $9.89 per share. KeyCorp also issued estimates for Sartorius Aktiengesellschaft’s Q4 2022 earnings at $2.67 EPS, FY2022 earnings at $9.89 EPS, FY2023 earnings at $11.11 EPS and FY2024 earnings at $12.83 EPS.
Several other brokerages have also recently weighed in on SARTF. UBS Group raised shares of Sartorius Aktiengesellschaft from a “neutral” rating to a “buy” rating in a research report on Monday, May 16th. HSBC began coverage on shares of Sartorius Aktiengesellschaft in a research report on Wednesday, June 22nd. They issued a “hold” rating on the stock. Finally, Berenberg Bank raised shares of Sartorius Aktiengesellschaft from a “hold” rating to a “buy” rating in a research report on Wednesday, April 13th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy”.
Sartorius Aktiengesellschaft Stock Performance
Shares of SARTF opened at $352.72 on Monday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.21 and a quick ratio of 0.58. The stock has a 50-day moving average of $343.61 and a 200-day moving average of $377.15. The company has a market cap of $12.07 billion, a PE ratio of 43.17 and a beta of 0.74. Sartorius Aktiengesellschaft has a one year low of $292.00 and a one year high of $947.00.
Ad Investing Daily
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Sartorius Aktiengesellschaft (OTCMKTS:SARTF – Get Rating) last issued its earnings results on Thursday, April 21st. The company reported $2.74 EPS for the quarter, beating the consensus estimate of $2.49 by $0.25. The company had revenue of $1.15 billion during the quarter, compared to the consensus estimate of $1.06 billion. Sartorius Aktiengesellschaft had a return on equity of 33.84% and a net margin of 12.80%.
Sartorius Aktiengesellschaft Company Profile
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to email@example.com.
Before you consider Sartorius Aktiengesellschaft, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Sartorius Aktiengesellschaft wasn’t on the list.
While Sartorius Aktiengesellschaft currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
This post was originally published on *this site*